- Morgan Stanley cut Guardant Health, Inc. (NASDAQ:GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.
- Oppenheimer cut the price target for Relmada Therapeutics, Inc. (NASDAQ:RLMD) from $75 to $64. Relmada Therapeutics shares fell 5.2% to close at $21.23 on Friday.
- Mizuho raised the price target on McKesson Corporation (NYSE:MCK) from $280 to $331. McKesson shares fell 0.8% to $331.36 in pre-market trading.
- Credit Suisse boosted the price target for Kellogg Company (NYSE:K) from $62 to $69. Kellogg shares fell 1.4% to $71.70 in pre-market trading.
- Barclays boosted the price target on EPAM Systems, Inc. (NYSE:EPAM) from $350 to $410. EPAM Systems shares fell 3.7% to $334.03 in pre-market trading.
Check out this: Snap And 2 Other Stocks Insiders Are Selling
- Wells Fargo raised the price target on Cigna Corporation (NYSE:CI) from $278 to $306. Cigna shares fell 0.7% to $265.00 in pre-market trading.
- Citigroup reduced Lucid Group, Inc. (NASDAQ:LCID) price target from $45 to $36. Lucid Group shares fell 4% to $17.42 in pre-market trading.
- Truist Securities reduced Virgin Galactic Holdings, Inc. (NYSE:SPCE) price target from $24 to $8. Virgin Galactic shares fell 3.9% to $6.53 in pre-market trading.
- JMP Securities cut Intellia Therapeutics, Inc. (NASDAQ:NTLA) price target from $165 to $110. Intellia Therapeutics shares dropped 5.2% to $45.07 in pre-market trading.
- Telsey Advisory Group lowered Under Armour, Inc. (NYSE:UAA) price target from $25 to $17. Under Armour shares fell 1% to $10.78 in pre-market trading.
Don’t forget to check out our premarket coverage here .
